US Stock MarketDetailed Quotes

TCON Tracon Pharmaceuticals

Watchlist

0.040
-0.013-25.02%

15min DelayClose Nov 4 16:00 ET

136.30KMarket Cap0.01P/E (TTM)

Tracon Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

52.67%-2.77M

49.17%-2.54M

114.01%3.68M

88.78%-522K

320.48%15.05M

27.02%-5.85M

25.79%-5M

-16.25%-26.24M

9.01%-4.65M

18.96%-6.83M

Net income from continuing operations

54.84%-2.84M

62.75%-3.17M

87.68%-3.59M

106.27%439K

267.26%10.76M

-0.90%-6.29M

10.23%-8.5M

-1.63%-29.14M

9.27%-7M

7.44%-6.44M

Depreciation and amortization

-50.00%4K

-27.27%8K

-51.43%34K

-36.36%7K

-87.10%8K

-66.67%8K

140.74%11K

218.64%70K

139.29%11K

444.44%62K

Other non cash items

----

852.83%7.41M

--0

2,808.70%669K

276,550.00%5.53M

17,200.00%1.21M

574.39%778K

6,116.67%746K

27.78%23K

Change In working capital

95.13%-273K

-86.96%234K

-800.42%-2.15M

-268.75%-1.46M

425.57%3.12M

-138.84%-5.61M

-18.52%1.8M

-105.26%-239K

-58.86%864K

51.44%-958K

-Change in prepaid assets

-0.73%271K

-94.36%15K

289.86%269K

-86.75%51K

46.85%-321K

254.55%273K

26.07%266K

186.25%69K

2.12%385K

12.34%-604K

-Change in payables and accrued expense

-117.44%-544K

-85.68%219K

-686.04%-2.42M

-415.03%-1.51M

-1,470.62%-5.56M

228.62%3.12M

-23.24%1.53M

-106.66%-308K

-72.20%479K

72.43%-354K

Cash from discontinued investing activities

Operating cash flow

52.67%-2.77M

49.17%-2.54M

114.01%3.68M

88.78%-522K

320.48%15.05M

27.02%-5.85M

25.79%-5M

-16.25%-26.24M

9.01%-4.65M

18.96%-6.83M

Investing cash flow

Cash flow from continuing investing activities

-100.43%-17K

55.56%-4K

22.22%-7K

Net PPE purchase and sale

----

--0

----

64.58%-17K

55.56%-4K

22.22%-7K

Net investment purchase and sale

----

--0

----

--0

----

Cash from discontinued investing activities

Investing cash flow

----

--0

----

-100.43%-17K

55.56%-4K

22.22%-7K

Financing cash flow

Cash flow from continuing financing activities

9.54%1.15M

132.13%1.87M

-163.70%-12.54M

-73.23%1.32M

-186.86%-9.09M

-78.87%1.05M

-748.40%-5.82M

86.40%19.68M

800.42%4.95M

-17.94%10.47M

Net issuance payments of debt

--0

-275.06%-20.5M

--0

-205.42%-10.5M

--0

-1,328.57%-10M

518.21%11.71M

590.00%3.43M

1,522.86%9.96M

Net common stock issuance

14.13%1.15M

-55.26%1.87M

0.47%7.92M

-10.01%1.32M

178.46%1.41M

-82.94%1.01M

29,757.14%4.18M

-40.36%7.88M

2,820.37%1.47M

-96.24%506K

Proceeds from stock option exercised by employees

----

-52.63%45K

-95.65%2K

--0

----

-36.24%95K

-4.17%46K

--0

Cash from discontinued financing activities

Financing cash flow

9.54%1.15M

132.13%1.87M

-163.70%-12.54M

-73.23%1.32M

-186.86%-9.09M

-78.87%1.05M

-748.40%-5.82M

86.40%19.68M

800.42%4.95M

-17.94%10.47M

Net cash flow

Beginning cash position

19.28%7.96M

-50.65%8.64M

-27.30%17.5M

-54.48%7.84M

-86.20%1.87M

-59.87%6.68M

-27.30%17.5M

-25.08%24.07M

-42.44%17.21M

-46.91%13.58M

Current changes in cash

66.25%-1.62M

93.78%-673K

-34.86%-8.86M

178.47%802K

64.12%5.96M

-56.96%-4.8M

-45.63%-10.82M

18.45%-6.57M

104.94%288K

-15.95%3.63M

End cash Position

238.47%6.34M

19.28%7.96M

-50.65%8.64M

-54.48%7.84M

-86.20%1.87M

-59.87%6.68M

-27.30%17.5M

-42.44%17.21M

Free cash flow

52.67%-2.77M

49.17%-2.54M

114.00%3.68M

88.79%-522K

320.25%15.05M

27.04%-5.85M

25.84%-5M

-16.08%-26.26M

9.10%-4.66M

18.96%-6.83M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	52.67%-2.77M	49.17%-2.54M	114.01%3.68M	88.78%-522K	320.48%15.05M	27.02%-5.85M	25.79%-5M	-16.25%-26.24M	9.01%-4.65M	18.96%-6.83M
Net income from continuing operations	54.84%-2.84M	62.75%-3.17M	87.68%-3.59M	106.27%439K	267.26%10.76M	-0.90%-6.29M	10.23%-8.5M	-1.63%-29.14M	9.27%-7M	7.44%-6.44M
Depreciation and amortization	-50.00%4K	-27.27%8K	-51.43%34K	-36.36%7K	-87.10%8K	-66.67%8K	140.74%11K	218.64%70K	139.29%11K	444.44%62K
Other non cash items	----	----	852.83%7.41M	--0	2,808.70%669K	276,550.00%5.53M	17,200.00%1.21M	574.39%778K	6,116.67%746K	27.78%23K
Change In working capital	95.13%-273K	-86.96%234K	-800.42%-2.15M	-268.75%-1.46M	425.57%3.12M	-138.84%-5.61M	-18.52%1.8M	-105.26%-239K	-58.86%864K	51.44%-958K
-Change in prepaid assets	-0.73%271K	-94.36%15K	289.86%269K	-86.75%51K	46.85%-321K	254.55%273K	26.07%266K	186.25%69K	2.12%385K	12.34%-604K
-Change in payables and accrued expense	-117.44%-544K	-85.68%219K	-686.04%-2.42M	-415.03%-1.51M	-1,470.62%-5.56M	228.62%3.12M	-23.24%1.53M	-106.66%-308K	-72.20%479K	72.43%-354K
Cash from discontinued investing activities
Operating cash flow	52.67%-2.77M	49.17%-2.54M	114.01%3.68M	88.78%-522K	320.48%15.05M	27.02%-5.85M	25.79%-5M	-16.25%-26.24M	9.01%-4.65M	18.96%-6.83M
Investing cash flow
Cash flow from continuing investing activities			0	0				-100.43%-17K	55.56%-4K	22.22%-7K
Net PPE purchase and sale	----	----	--0	--0	----	----	----	64.58%-17K	55.56%-4K	22.22%-7K
Net investment purchase and sale	----	----	--0	----	----	----	----	--0	----	----
Cash from discontinued investing activities
Investing cash flow	----	----	--0	--0	----	----	----	-100.43%-17K	55.56%-4K	22.22%-7K
Financing cash flow
Cash flow from continuing financing activities	9.54%1.15M	132.13%1.87M	-163.70%-12.54M	-73.23%1.32M	-186.86%-9.09M	-78.87%1.05M	-748.40%-5.82M	86.40%19.68M	800.42%4.95M	-17.94%10.47M
Net issuance payments of debt	--0	--0	-275.06%-20.5M	--0	-205.42%-10.5M	--0	-1,328.57%-10M	518.21%11.71M	590.00%3.43M	1,522.86%9.96M
Net common stock issuance	14.13%1.15M	-55.26%1.87M	0.47%7.92M	-10.01%1.32M	178.46%1.41M	-82.94%1.01M	29,757.14%4.18M	-40.36%7.88M	2,820.37%1.47M	-96.24%506K
Proceeds from stock option exercised by employees	----	----	-52.63%45K	-95.65%2K	--0	----	----	-36.24%95K	-4.17%46K	--0
Cash from discontinued financing activities
Financing cash flow	9.54%1.15M	132.13%1.87M	-163.70%-12.54M	-73.23%1.32M	-186.86%-9.09M	-78.87%1.05M	-748.40%-5.82M	86.40%19.68M	800.42%4.95M	-17.94%10.47M
Net cash flow
Beginning cash position	19.28%7.96M	-50.65%8.64M	-27.30%17.5M	-54.48%7.84M	-86.20%1.87M	-59.87%6.68M	-27.30%17.5M	-25.08%24.07M	-42.44%17.21M	-46.91%13.58M
Current changes in cash	66.25%-1.62M	93.78%-673K	-34.86%-8.86M	178.47%802K	64.12%5.96M	-56.96%-4.8M	-45.63%-10.82M	18.45%-6.57M	104.94%288K	-15.95%3.63M
End cash Position	238.47%6.34M	19.28%7.96M	-50.65%8.64M	-50.65%8.64M	-54.48%7.84M	-86.20%1.87M	-59.87%6.68M	-27.30%17.5M	-27.30%17.5M	-42.44%17.21M
Free cash flow	52.67%-2.77M	49.17%-2.54M	114.00%3.68M	88.79%-522K	320.25%15.05M	27.04%-5.85M	25.84%-5M	-16.08%-26.26M	9.10%-4.66M	18.96%-6.83M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data